Infosys Limited (INFY), the India-based information technology and consulting company whose American Depositary Shares trade on the NYSE, has seen its analyst coverage turn cautious after a steep decline and repeated guidance reductions. Recent individual targets include $13 from Stifel and $13 from BMO Capital (both reiterated in late October 2026), $11 from TD Cowen, $10 from Goldman Sachs, and $11 from Wells Fargo. That handful of named targets averages roughly $11.60, below the recent share price.
Broader polls point in the same direction. S&P Global data covering 14 analysts shows an average target near $12.07 within a range of roughly $10.40 to $14.30, while FactSet data spanning 45 analysts shows a mean near $12.31. Because these aggregate figures sit at or below the market price, no credible consensus target clears the roughly 10% threshold needed for a meaningful upside objective.
For that reason, the $14 central target used here is drawn from public discussion, not from a consensus calculation. Multiple sell-side firms — including those framing roughly 13% upside — imply an objective near $14, while a few more bullish voices point toward the mid-teens. Readers should treat $14 as a widely discussed aspiration, not a forecast or a guarantee.
Infosys shares trade near $12.43, down roughly 28% to 31% year to date and far below their 52-week high of about $30, with a 52-week low near $10.12. Reaching $14 would require a gain of approximately 12.6% — a meaningful but not extreme move for a stock that has already repriced sharply lower.
The path would depend on stabilization in discretionary technology spending and evidence that recent large-deal wins convert into revenue. Infosys reported quarterly revenue of about $5.1 billion, up 1.2% sequentially in constant currency, but cut its fiscal 2027 constant-currency revenue growth guidance to 1%–2% from 1.5%–3% — its weakest annual outlook in seven years. A return toward the target would likely require the company to hold its 20%–22% operating margin while bookings momentum translates into growth.
The most constructive signals are on the demand side. Large-deal total contract value reached $5.2 billion in the quarter, with 62% from net-new business, including a seven-year, roughly $2 billion mega-deal expected to contribute about a point of growth next fiscal year. AI services revenue rose 29% sequentially to about $540 million, or 10.5% of revenue.
Valuation also provides support. With a P/E (price-to-earnings) ratio in the low-to-mid teens and a long history of strong free cash flow and shareholder returns, the stock is no longer priced for aggressive growth. Any improvement in pricing realization, deal conversion, or enterprise IT budgets could justify a re-rating toward the $14 area.
The central obstacle is the company's own guidance. Infosys cut its fiscal 2027 growth outlook for the second straight quarter, citing softer volumes, weaker pricing realization, competitive intensity, and AI-driven productivity pass-throughs that are deflating legacy services revenue. Wage hikes in the second half, softer seasonality, and a decision to walk away from a large European manufacturing deal add pressure.
Macro conditions remain a headwind, with geopolitical tensions, tariffs, and inflation extending client decision cycles. If discretionary spending stays weak or pricing continues to erode, the stock could remain range-bound or retest its 52-week low rather than advance toward $14.
The $10.12 52-week low stands as the key support level, while the $13 area — home to several recent analyst targets — represents near-term resistance. A decisive move above $13 would bring the $14 objective into view. The stock's long-term structure remains deeply impaired, however, with shares still far below the prior high near $30, meaning any recovery must first repair the intermediate downtrend.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary. For Infosys, the near-term catalysts are quarterly earnings, any further revisions to the fiscal 2027 guidance, and commentary on deal conversion and pricing. Investors should also watch large-deal ramp-ups, AI services revenue growth, margin delivery through the wage-hike cycle, and any shift in enterprise IT spending sentiment.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a name as volatile as Infosys, these signals can help traders identify shifting momentum and potential turning points without manually tracking every indicator. Traders can use the tool to discover opportunities, monitor existing positions, and spot changing trends more efficiently.
Whether Infosys can reach $14 depends less on any single catalyst than on a broad stabilization in IT-services demand. The $14 objective — a public-discussion level reflecting roughly 13% upside — is achievable in percentage terms but far from guaranteed, given that the average analyst target still sits below the current price. Strong deal bookings, a major mega-deal, and expanding AI revenue argue for eventual recovery, while weak pricing, AI-led deflation, and a trimmed growth outlook argue for patience. Investors should watch guidance revisions, margin delivery, and deal-to-revenue conversion as the decisive signals.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, INFY has been closely correlated with CTSH. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if INFY jumps, then CTSH could also see price increases.
| Ticker / NAME | Correlation To INFY | 1D Price Change % | ||
|---|---|---|---|---|
| INFY | 100% | +2.60% | ||
| CTSH - INFY | 73% Closely correlated | +3.05% | ||
| GLOB - INFY | 70% Closely correlated | +4.96% | ||
| ACN - INFY | 69% Closely correlated | +3.81% | ||
| EPAM - INFY | 64% Loosely correlated | -0.59% | ||
| G - INFY | 63% Loosely correlated | +1.39% | ||
More | ||||
| Ticker / NAME | Correlation To INFY | 1D Price Change % |
|---|---|---|
| INFY | 100% | +2.60% |
| INFY (4 stocks) | 73% Closely correlated | +3.61% |
| Technology Services (397 stocks) | 11% Poorly correlated | +1.75% |